Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

Employment among patients with kidney disease remains low even after dialysis or a transplant, with physical and social ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

For a disease afflicting 35.5 million people in the U.S., chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed.

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

(Courtesy/GettyImages) Millions of people around the world unknowingly live with a deadly trio: diabetes, high blood pressure and kidney disease. Often, they only realise the connection when it is ...

Raad B. Chowdhury, MD, and Shruti Gupta, MD, MPH, are onconephrologists in the Division of Nephrology at Brigham and Women's Hospital (BWH). They are first and senior authors, respectively, of a paper ...

Diabetes and high blood pressure are the two main culprits of chronic kidney disease (CKD), a long-term condition in which ...

A Diabetes, Heart Failure, and Kidney Disease Medication Is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes Feb. 11, 2025 — Over 1,000 genes may serve as possible ...